Compass Therapeutics Inc.

NASDAQ: CMPX · Real-Time Price · USD
2.98
0.03 (1.02%)
At close: Aug 15, 2025, 3:59 PM
2.97
-0.34%
After-hours: Aug 15, 2025, 05:01 PM EDT

Compass Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-49.38M -42.49M -39.23M -82.18M
Depreciation & Amortization
1.75M 1.89M 1.9M 1.62M
Stock-Based Compensation
8.56M 6.12M 5.33M 4.03M
Other Working Capital
-2.3M -3.62M -3.78M 6.44M
Other Non-Cash Items
-1.65M 5.97M -871K 41K
Deferred Income Tax
n/a n/a n/a 50.58M
Change in Working Capital
-4.14M -2.91M -1.26M 6.25M
Operating Cash Flow
-44.85M -40.62M -34.13M -19.67M
Capital Expenditures
-44K -30K -212K -1.57M
Cash Acquisitions
n/a n/a 176K 116K
Purchase of Investments
-88.16M -155.42M -200.12M n/a
Sales Maturities Of Investments
134.97M 182.41M 48.95M n/a
Other Investing Acitivies
n/a 27K -150.99K -318K
Investing Cash Flow
46.77M 26.96M -151.2M -1.77M
Debt Repayment
n/a n/a n/a n/a
Common Stock Repurchased
n/a -159 n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
-775K -159K -480K -281K
Financial Cash Flow
17.34M 2.94M 75.76M 118.61M
Net Cash Flow
19.25M -10.72M -109.57M 97.17M
Free Cash Flow
-44.9M -40.65M -34.34M -21.23M